CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 462 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01756235
NCT01756235N/ACompleted
CompareCT.gov

Physical ACtivity in patiEnts With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice (PACE)

AbbVie (prior sponsor, Abbott)·observational·Posted Dec 25, 2012·Updated Mar 6, 2017

In Brief

An observational study for Rheumatoid Arthritis. Completed, enrolled 462 participants.

Detailed Summary

The purpose of this study was to evaluate physical activity and its changes in participants with rheumatoid arthritis (RA) who were treated with adalimumab therapy in clinical practice.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 25, 2012
Enrollment StartDec 1, 2012
Primary CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 13.5 years ago